Fig. 7

Prospects of GAA as a therapeutic agent for TNBC. A The MSNPs platform consists of a bare mesoporous silica core surrounded by PEG2000 and a lipid bilayer shell. The mesoporous silica core can be loaded with GAA. B TEM images of GAA MSNPs. C Representative IHC images and quantification of IHC intensity of LRPPRC protein in subcutaneous TNBC tissues treated with GAA MSNPs. Data were summarized from independent experiments in triplicates and shown in the pie graph. D Tumor volume of subcutaneous TNBC tissues with postinjection time treated with GAA MSNPs. Two-way ANOVA test was used. H Tumor weight of subcutaneous TNBC tissues treated with GAA MSNPs. Unpaired t-test was used